- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05132751
Machine Learning Ventilator Decision System VS. Standard Controlled Ventilation
November 12, 2021 updated by: Hu Anmin
Effect of a Machine Learning Ventilator Decision System Versus Standard Controlled Ventilation on in Critical Care: a Randomized Trial
Ventilator-induced lung injury is associated with increased morbidity and mortality.
Despite intense efforts in basic and clinical research, an individualized ventilation strategy for critically ill patients remains a major challenge.
However, an individualized mechanical ventilation approach remains a challenging task: A multitude of factors, e.g., lab values, vitals, comorbidities, disease progression, and other clinical data must be taken into consideration when choosing a patient's specific optimal ventilation regime.
The aim of this work was to evaluate the machine learning ventilator decision system, which is able to suggest a dynamically optimized mechanical ventilation regime for critically-ill patients.
Compare with standard controlled ventilation, to test whether the clinical application of the machine learning ventilator decision system reduces mechanical ventilation time and mortality.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- only the first ICU stay was eligible;
- adults ≥ 18 years of age on ICU admission;
- estimate mechanical ventilation time ≥24 hours;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Machine Learning Ventilator Decision System Ventilation
|
Artificial intelligence ventilator system for personalized mechanical ventilation
|
|
Active Comparator: Group B
Standard Controlled Ventilation
|
Artificial intelligence ventilator system for personalized mechanical ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mechanical ventilation time
Time Frame: through study completion, an average of 5 days
|
through study completion, an average of 5 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of ICU stay time
Time Frame: through study completion, an average of 1 week
|
through study completion, an average of 1 week
|
|
Length of hospital stay
Time Frame: through study completion, an average of 2 weeks
|
through study completion, an average of 2 weeks
|
|
In-hospital mortality
Time Frame: through study completion, an average of 2 weeks
|
through study completion, an average of 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2022
Primary Completion (Anticipated)
January 1, 2022
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
October 7, 2021
First Submitted That Met QC Criteria
November 12, 2021
First Posted (Actual)
November 24, 2021
Study Record Updates
Last Update Posted (Actual)
November 24, 2021
Last Update Submitted That Met QC Criteria
November 12, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LL-KY-2021396
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.